Cargando…
Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway
BACKGROUND: Prevention of metabolic complications of long‐term adjuvant endocrine therapy in breast cancers remained a challenge. We aimed to investigate the molecular mechanism in the development of tamoxifen (TAM)‐induced fatty liver in both estrogen receptor (ER)‐positive and ER‐negative breast c...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240857/ https://www.ncbi.nlm.nih.gov/pubmed/32508033 http://dx.doi.org/10.1002/ctm2.5 |